A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831

NCT00668070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis

Interventions

DRUG: ASP9831
DRUG: Placebo

Sponsor

Astellas Pharma Inc